In Vitro Antibacterial Efficacy of a New TiO

Mahalakshmi Pandian, Sacha Cavelier, Simone Guttau, Silvia Cometta, Joseph Fernando, Philipp Kobbe, Dietmar W Hutmacher

Abstract read

In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mahalakshmi PandianARC Training Centre for Cell and Tissue Engineering Technologies, Queensland University of Technology, Kelvin Grove, QLD 4059, Australia.

Sacha CavelierARC Training Centre for Cell and Tissue Engineering Technologies, Queensland University of Technology, Kelvin Grove, QLD 4059, Australia.ORCID 0000-0003-4756-6266

Simone GuttauStryker Trauma GmbH, 24232 Schönkirchen, Germany.

Silvia ComettaSchool of Mechanical, Medical and Process Engineering, Faculty of Engineering, Queensland University of Technology, Kelvin Grove, QLD 4059, Australia.ORCID 0000-0001-8928-5337

Joseph FernandoMax Planck Queensland Centre for the Materials Science of Extracellular Matrices, Queensland University of Technology, Kelvin Grove, QLD 4059, Australia.ORCID 0000-0003-0129-359X

Philipp KobbeDepartment for Trauma and Reconstructive Surgery, University Hospital of the Martin Luther University Halle, Universitätsring 19/20, 06099 Halle (Saale), Germany.ORCID 0009-0008-8020-0788

Dietmar W HutmacherARC Training Centre for Cell and Tissue Engineering Technologies, Queensland University of Technology, Kelvin Grove, QLD 4059, Australia.ORCID 0000-0001-5678-2134

Funding

Australian Research Council IC190100026Stryker TR-T2AL-ARTI-2147892

6 · The paper itself

Abstract

Despite advancements in surgical care, the management of surgical site infections (SSIs) associated with fracture-fixation devices is still a challenge after implant fixation, especially in open fractures.

Indexed as

antibacterial surfacescopperelectrochemical depositionintramedullary nailmetallic coatingsS. aureussurgical site infectiontitanium implants

Identifiers

PMID41295647

DOI10.3390/nano15221742

PMCPMC12655840

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.